CD40 Ligand
CD40 Ligand Uses, Dosage, Side Effects, Food Interaction and all others data.
CD40 Ligand is under investigation in clinical trial NCT00053391 (Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma).
| Trade Name | CD40 Ligand |
| Generic | Recombinant CD40-ligand |
| Recombinant CD40-ligand Other Names | CD40 ligand, Recombinant CD40-ligand |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here CD40 Ligand
